Medicines and Healthcare products Regulatory Agency

gov.uk Imported from official source

UK medicines and medical devices regulator; recalls and safety alerts.

Publications 151

  1. Transparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2026-27

    HRA transactions over £500 made using the government procurement card (GPC).

    Alert Safety
  2. Guidance: London Region I MHRA Regulatory Sandbox: call for expressions of interest

    Expressions of interest are invited from AI-enabled medical device manufacturers and NHS provider organisations interested in participating in the London Region I MHRA Regulatory Sandbox.

    Alert AI
  3. Field Safety Notices: 8 -12 June 2026

    List of Field Safety Notices for 8-12 June 2026

    Alert Safety
  4. Consultation on the regulation of Gene therapy medicinal products

    We are seeking views on proposed updates to the definition of Gene therapy medicinal products to better reflect advances in science and manufacturing.

    Alert Safety
  5. MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults 

    As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.

    Alert Safety
  6. Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices

    This consultation invites views on proposals for recognising CE marked medical devices in Great Britain.

    Alert Safety
  7. Decision: Marketing authorisations Granted in 2026

    Marketing authorisations granted in 2026.

    Alert
  8. Decision: Parallel import licences granted in 2026

    Parallel import licences granted in 2026.

    Alert
  9. Guidance: The Centres of Excellence for Regulatory Science and Innovation programme (CERSIs)

    A national programme to help drive advancements in healthcare, to ensure patients benefit from innovation and new treatments sooner.

    Alert Safety
  10. National assessment procedure for medicines

    Guidance on the MHRA’s national assessment procedure for marketing authorisation applications.

    Alert Safety
  11. Transparency data: MHRA Performance Data

    Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline to complete a specific regulatory function.

    Alert Safety
  12. Field Safety Notices: 27 to 31 January 2025

    List of Field Safety Notices from 27 to 31 January 2025.

    Alert Safety
  13. Guidance: Innovative Licensing and Access Pathway (ILAP)

    The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.

    Alert Safety
  14. Corporate report: MHRA-NICE Real-World Evidence Scientific Dialogue

    A programme to help decision making across the lifecycle of products, benefitting both regulatory and health technology assessment (HTA) evaluations.

    Alert Safety
  15. Pre-submission Advice & Support for Innovative Medicines

    The Medicines and Healthcare products Regulatory Agency (MHRA) offer a pre-submission service before applying for medicines Marketing Authorisations and clinical variations innovative medicines.

    Alert Safety
  16. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines

    Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.

    Alert Safety
  17. Guidance: The Innovative Devices Access Pathway (IDAP)

    The Innovative Devices Access Pathway (IDAP) pilot is designed to accelerate the development of innovative medical devices that meet an unmet clinical need in the NHS and support their integration ...

    Alert Safety
  18. Guidance: International Recognition Procedure

    How to use the procedure for medicines licensing applications.

    Alert Safety
  19. Decision: Human medicines: register of electronic export certificates

    Department of Health and Social Care and MHRA register of electronic export certificates (human).

    Alert Safety
  20. Guidance: Good machine learning practice for medical device development

    10 guiding principles that can inform the development of good machine learning practice (GMLP).

    Alert AI
  21. Guidance: COVID-19 test validation approved products

    Find out which COVID-19 test products have been approved.

    Alert Safety
  22. COVID-19 test approval: how to apply

    How manufacturers or distributors of Coronavirus (COVID-19) test devices can apply for approval of their tests to be placed on the UK market.

    Alert Safety
  23. Decision: Orphan registered medicinal products

    A list of authorised orphan medicinal products registered by the UK licensing authority.

    Alert Safety
  24. Register medical devices to place on the market

    How to register your medical devices with the MHRA for the markets in Great Britain and Northern Ireland.

    Alert Safety
  25. Renewing marketing authorisations for medicines

    How to renew marketing authorisations for products granted through different routes and at different times.

    Alert Safety
  26. Guidance: Guidance on pharmacovigilance procedures

    This guidance summarises our approach to pharmacovigilance

    Alert Safety
  27. Access, new active substance and biosimilar work sharing initiatives

    Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.

    Alert Safety
  28. Decision: Medical devices given exceptional use authorisations

    List of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled.

    Alert Safety
  29. Opportunities for patients and the public to be involved in the work of the MHRA

    How we engage and involve patients and the public in our regulatory decision-making.

    Alert Safety
  30. Find product information about medicines

    How to get information including patient information leaflets (PILs), details on how the medicine can be used (SPCs) and scientific reports (PARs).

    Alert Safety
  31. Guidance: Medicines that you cannot export from the UK or hoard

    Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.

    Alert Safety
  32. Safety Public Assessment Reports

    These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.

    Alert Safety
  33. Decision: Human and veterinary medicines: register of licensed manufacturing sites

    The MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only.

    Alert Safety
  34. Decision: Human medicines: register of licensed wholesale distribution sites

    Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human).

    Alert Safety
  35. Official Statistics: Quarterly reports on the import of unlicensed medicines

    Details and statistics on the import of unlicensed medicines from March 2014 onwards.

    Alert Safety
  36. Notice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences

    UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.

    Alert Safety
  37. Decision: Medicines: new manufacturing and wholesale dealer licences

    List of sites granted a manufacturer or wholesale dealer licence.

    Alert Safety
  38. Advanced therapy medicinal products: regulation and licensing in UK

    How to get a marketing authorisation (MA) for an advanced therapy medicinal product (ATMP) so it can be sold and/or supplied in the United Kingdom.

    Alert Safety
  39. Guidance: Herbal medicines granted a traditional herbal registration (THR)

    A list of herbal medicines currently holding a traditional herbal registration (THR) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).

    Alert Safety
  40. Guidance: Antidepressants: use and safety

    Guidance on the use and side effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs), their safety, use in pregnancy and the risk of s...

    Alert Safety
  41. Clinical investigations for medical devices

    How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.

    Alert Safety
  42. Good laboratory practice (GLP) for safety tests on chemicals

    Keep up to date with the latest information from the UK GLP monitoring authority.

    Alert Safety
  43. Apply for a licence to market a medicine in the UK

    An overview of the process to get a marketing authorisation (MA), including submitting, fast-tracking an application, naming your medicine and paying fees.

    Alert Safety
  44. Medicines: apply for a variation to your marketing authorisation

    Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.

    Alert Safety
  45. Clinical trials for medicines: Good clinical practice inspections

    Information relating to good clinical practice (GCP) inspections.

    Alert Safety
  46. Medicines: reclassify your product

    Pharmacy (P), prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.

    Alert Safety
  47. Notice: Register of brokers authorised to deal in human medicines

    Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.

    Alert Safety
  48. Decision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients

    Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.

    Alert Safety
  49. Send and receive information on adverse drug reactions (ADRs)

    How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.

    Alert Safety
  50. Guidance: Magnetic resonance imaging equipment in clinical use: safety guidelines

    Relevant safety information for users of magnetic resonance imaging (MRI) equipment in clinical use.

    Alert Safety

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.